Genprex to Present and Participate at Upcoming May Investor and Industry Conferences

AUSTIN, Texas — (May. 1, 2024) — Genprex, Inc. ("Genprex" or the "Company") (NASDAQ: GNPX), a clinical-stage gene therapy company focused on developing life-changing therapies for patients with

GenprexMay 1 00:00 ET

12 Health Care Stocks Moving In Friday's Pre-Market Session

GainersTevogen Bio Holdings (NASDAQ:TVGN) shares rose 75.3% to $1.49 during Friday's pre-market session. The company's market cap stands at $245.2 million. Cryo-Cell International (AMEX:CCEL) shares i

BenzingaApr 26 08:06 ET

Analysts Offer Insights on Healthcare Companies: Genprex (GNPX) and SurModics (SRDX)

TipRanksApr 10 10:50 ET

Analysts Have Conflicting Sentiments on These Healthcare Companies: Evaxion Biotech (EVAX), 60 Degrees Pharmaceuticals, Inc. (SXTP) and Genprex (GNPX)

TipRanksApr 3 06:31 ET

Express News | HC Wainwright & Co. Reiterates Buy on Genprex, Maintains $10 Price Target

Moomoo 24/7Apr 3 06:23 ET

Genprex Expands Clinical Trial Sites for Acclaim-3 Clinical Study of Reqorsa Therapy in Combination With Tecentriq to Treat Small Cell Lung Cancer

Multiple clinical trial sites to be opened under collaboration with large network of community-based oncology practices Acclaim-3 Study Supported by FDA Orphan Drug a

GenprexApr 3 00:00 ET